SCHEMBL5879183

SCHEMBL5879183

Cn1c(=O)c2c3[nH]c4ccccc4c3c3c(=O)n(CCCO)c(=O)c3c2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
HPGD P15428 1/20 0.56
CDK4 P11802 4/20 0.52
CCND1 P24385 4/20 0.52
CCNE2 O96020 2/20 0.52
CCNE1 P24864 2/20 0.52
CDK2 P24941 2/20 0.52
CHEK1 O14757 2/20 0.44
TSHR P16473 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
PRKCA P17252 1/20 0.41
MPO P05164 4/20 0.41
XDH P47989 2/20 0.40
PRKACA P17612 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5879324 0.85 ALDH1A1 (0.56) ALDH1A1HPGDCHEK1KDM4EHSD17B10
SCHEMBL5879141 0.85 CHEK1 (0.59) ALDH1A1HPGDCDK4CCND1CCNE2
SCHEMBL5879155 0.81 CHEK1 (0.51) ALDH1A1HPGDCDK4CCND1CCNE2
SCHEMBL5879203 0.81 MPO (0.58) ALDH1A1HPGDCHEK1TSHRKDM4E
SCHEMBL6201693 0.81 MPO (0.58) ALDH1A1HPGDCHEK1TSHRKDM4E
SCHEMBL5879158 0.80 CHEK1 (0.71) ALDH1A1HPGDCDK4CCND1CCNE2
Hydrochloric Acid SCHEMBL5879263 0.80 MPO (0.57) ALDH1A1HPGDCHEK1TSHRKDM4E
Hydrochloric Acid SCHEMBL5879295 0.80 MPO (0.57) ALDH1A1HPGDCHEK1TSHRKDM4E
SCHEMBL5879140 0.79 CHEK1 (0.51) ALDH1A1HPGDCDK4CCND1CCNE2
SCHEMBL5879196 0.78 CHEK1 (0.50) ALDH1A1HPGDCDK4CCND1CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151108-B2 Anticarcinogenic, antiproliferative, and antitumor agents LES LABORATORIES SERVIER (FR) 2006-12-19 US disclosed
EP-1411057-B1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-04-27 EP disclosed
US-20040077672-A1 Anticarcinogenic, antiproliferative, and antitumor agents LES LABORATOIRES SERVIER (FR) 2004-04-22 US disclosed
EP-1411057-A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2004-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077672-A1 Anticarcinogenic, antiproliferative, and antitumor agents XDH, TOP2A, TOP1 ALDH1A1 286/4885HPGD 439/4885CDK4 1989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.